{"id":"W2597981368","doi":"10.1200/jco.2014.32.15_suppl.8519","title":"Preliminary results of a phase II randomized study (ROMULUS) of polatuzumab vedotin (PoV) or pinatuzumab vedotin (PiV) plus rituximab (RTX) in patients (Pts) with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL).","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Neutropenia; Gastroenterology; Rituximab; Adverse effect; Febrile neutropenia; Refractory (planetary science); Nausea; Diarrhea; Lymphoma; Surgery; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002691991,0.001303006,0.001457517,0.0003741962,0.0003383605,0.001009627,0.0008835172,0.001315009,0.004920278],"category_scores_gemma":[0.002092373,0.0005294916,0.001103343,0.0003635085,0.001154676,0.001086403,0.0004499005,0.001989697,0.000775463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007127285,"about_ca_system_score_gemma":0.0009904206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005479828,"about_ca_topic_score_gemma":0.001380356,"domain_scores_codex":[0.9988834,0.000796944,0.00005255854,0.00009575799,0.00004823107,0.0001231],"domain_scores_gemma":[0.9987651,0.0004237856,0.0002190183,0.00008123758,0.00004247711,0.0004683455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9280114,0.0214143,0.001623198,0.0004460756,0.0008695875,0.0001243138,0.0001373577,0.0006527313,0.01009369,0.0001419919,0.001194681,0.03529079],"study_design_scores_gemma":[0.814947,0.1787713,0.003320646,0.00001664908,0.0003588346,0.00008726768,0.00002503279,0.0003757216,0.0009489762,0.0001449871,0.0009903016,0.00001328315],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881383,0.002269448,0.000892062,0.0006011561,0.0002365477,0.004675185,0.001138719,0.0001074705,0.001941185],"genre_scores_gemma":[0.9878255,0.001227023,0.002118496,0.001092193,0.0003991797,0.003520106,0.001709134,0.00003127617,0.002077113],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004920278,"threshold_uncertainty_score":0.01645994,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04150048108431231,"score_gpt":0.3980693829016003,"score_spread":0.356568901817288,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}